Company Filing History:
Years Active: 1998
Title: The Innovative Contributions of Sarah Slaymaker
Introduction
Sarah Slaymaker is a prominent inventor based in Stanford, California. She has made significant contributions to the field of immunology, particularly in understanding T-cell behavior. Her work focuses on the mechanisms of T-cell anergy, which is crucial for developing therapies for autoimmune diseases and improving transplant acceptance.
Latest Patents
Sarah holds a patent for her invention titled "Anergy genes." This patent encompasses methods and compositions for identifying genes associated with the induction of anergy in T-cells. The invention also includes the use of nucleic acids or proteins as diagnostics for monitoring the induction of tolerance in physiological samples. Notably, a cysteine string protein is identified as a marker for quiescent T-cells, which is lost in anergic T-cells. This innovative approach has the potential to elucidate pathways to anergy or activation in T-cells.
Career Highlights
Sarah Slaymaker is affiliated with Leland Stanford Junior University, where she conducts her research and contributes to the academic community. Her work has garnered attention for its implications in both basic and applied sciences. With a focus on T-cell dynamics, she is paving the way for advancements in immunotherapy.
Collaborations
Some of Sarah's notable coworkers include Debra Bloom and C. Garrison Fathman. Their collaborative efforts enhance the research environment and contribute to the advancement of knowledge in immunology.
Conclusion
In summary, Sarah Slaymaker's innovative work in T-cell research and her patent on anergy genes highlight her significant contributions to the field. Her research not only advances scientific understanding but also holds promise for future therapeutic applications.